TY 2022 Form 990 Schedule J

(A) Name and Title		(B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column (B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1Robert C Garrett CEO/Trustee	(i) (ii)	2,549,241 ------------- 0	1,832,399 ------------- 0	1,292,784 ------------- 0	277,938 ------------- 0	32,417 ------------- 0	5,984,779 ------------- 0	250,000 ------------- 0
2Mark Stauder Chairperson/COO	(i) (ii)	1,697,375 ------------- 0	936,749 ------------- 0	277,208 ------------- 0	15,250 ------------- 0	31,009 ------------- 0	2,957,591 ------------- 0	0 ------------- 0
3Robert L Glenning Pres, Fin & IT Svcs Div, CFO	(i) (ii)	1,378,293 ------------- 0	655,678 ------------- 0	578,577 ------------- 0	15,250 ------------- 0	37,883 ------------- 0	2,665,681 ------------- 0	0 ------------- 0
4Ihor Sawczuk MD Reg. Pres, Hospitals	(i) (ii)	1,663,959 ------------- 0	542,697 ------------- 0	335,365 ------------- 0	27,938 ------------- 0	29,940 ------------- 0	2,599,899 ------------- 0	0 ------------- 0
5Audrey C Murphy ESQ EVP, Co-Chief Legal Officer	(i) (ii)	947,437 ------------- 0	284,437 ------------- 0	847,509 ------------- 0	27,938 ------------- 0	40,325 ------------- 0	2,147,646 ------------- 0	133,822 ------------- 0
6Patrick Young Pres, Population Health	(i) (ii)	1,017,079 ------------- 0	588,004 ------------- 0	234,002 ------------- 0	424,346 ------------- 0	40,067 ------------- 0	2,303,498 ------------- 0	150,001 ------------- 0
7Kenneth N Sable MD Reg Pres, Hospitals	(i) (ii)	1,082,568 ------------- 0	403,017 ------------- 0	235,909 ------------- 0	186,282 ------------- 0	44,646 ------------- 0	1,952,422 ------------- 0	127,468 ------------- 0
8Daniel Varga MD Chief Physician Executive	(i) (ii)	1,092,955 ------------- 0	409,415 ------------- 0	194,560 ------------- 0	15,250 ------------- 0	41,248 ------------- 0	1,753,428 ------------- 0	0 ------------- 0
9Mark D Sparta MD Pres HMH North Reg	(i) (ii)	1,050,380 ------------- 0	277,070 ------------- 0	276,311 ------------- 0	104,720 ------------- 0	40,987 ------------- 0	1,749,468 ------------- 0	56,930 ------------- 0
10James Blazar EVP, Chief Strategy Officer	(i) (ii)	975,093 ------------- 0	331,817 ------------- 0	236,983 ------------- 0	15,250 ------------- 0	34,494 ------------- 0	1,593,637 ------------- 0	0 ------------- 0
11Timothy J Hogan President, CTS	(i) (ii)	804,164 ------------- 0	268,247 ------------- 0	399,751 ------------- 0	24,400 ------------- 0	29,982 ------------- 0	1,526,544 ------------- 0	0 ------------- 0
12Donna Snider CFA SVP, Chief Investment Officer	(i) (ii)	728,900 ------------- 0	558,348 ------------- 0	36,850 ------------- 0	108,669 ------------- 0	37,567 ------------- 0	1,470,334 ------------- 0	0 ------------- 0
13Ann B Gavzy Esq EVP, Co-Chief Legal Officer	(i) (ii)	855,939 ------------- 0	273,827 ------------- 0	248,709 ------------- 0	24,400 ------------- 0	32,769 ------------- 0	1,435,644 ------------- 0	0 ------------- 0
14Andre Goy Phys in Chief Onc	(i) (ii)	829,012 ------------- 0	268,445 ------------- 0	255,822 ------------- 0	15,250 ------------- 0	29,607 ------------- 0	1,398,136 ------------- 0	0 ------------- 0
15Todd Way Reg President, Hospitals	(i) (ii)	868,294 ------------- 0	318,012 ------------- 0	158,887 ------------- 0	15,250 ------------- 0	30,897 ------------- 0	1,391,340 ------------- 0	106,563 ------------- 0
16Linda McHugh EVP CHIEF EXP OFF, Vice Chair	(i) (ii)	887,969 ------------- 0	234,914 ------------- 0	207,870 ------------- 0	15,250 ------------- 0	30,875 ------------- 0	1,376,878 ------------- 0	22,500 ------------- 0
17Jeffrey Boscamp Interim, Pres & Dean, SOM	(i) (ii)	694,999 ------------- 0	198,746 ------------- 0	283,283 ------------- 0	10,675 ------------- 0	3,877 ------------- 0	1,191,580 ------------- 0	0 ------------- 0
18Joyce Hendricks Chief Devel Officer	(i) (ii)	619,110 ------------- 0	360,943 ------------- 0	145,032 ------------- 0	15,250 ------------- 0	28,957 ------------- 0	1,169,292 ------------- 0	0 ------------- 0
19James Clarke EVP & Pres, Physician Services	(i) (ii)	681,002 ------------- 0	238,031 ------------- 0	176,522 ------------- 0	15,250 ------------- 0	29,749 ------------- 0	1,140,554 ------------- 0	0 ------------- 0
20Jawad Kirmani Physician, Leader	(i) (ii)	849,103 ------------- 0	196,363 ------------- 0	24,477 ------------- 0	15,250 ------------- 0	37,251 ------------- 0	1,122,444 ------------- 0	0 ------------- 0
21Thomas Steineke Physician, Leader	(i) (ii)	977,739 ------------- 0	0 ------------- 0	28,355 ------------- 0	15,250 ------------- 0	37,439 ------------- 0	1,058,783 ------------- 0	0 ------------- 0
22Anne Goodwill-Pritchett EVP, Revenue Operations	(i) (ii)	637,391 ------------- 0	152,212 ------------- 0	193,587 ------------- 0	15,250 ------------- 0	15,860 ------------- 0	1,014,300 ------------- 0	0 ------------- 0
23Paul K Chung MD Trustee/MPI Physician	(i) (ii)	685,058 ------------- 0	20,000 ------------- 0	243,560 ------------- 0	15,250 ------------- 0	36,818 ------------- 0	1,000,686 ------------- 0	0 ------------- 0
24Theresa Brodrick EVP, Chief Nursing Executive	(i) (ii)	538,181 ------------- 0	179,937 ------------- 0	120,406 ------------- 0	102,288 ------------- 0	28,957 ------------- 0	969,769 ------------- 0	79,125 ------------- 0
25Kash Patel EVP, Chief Digital, Info Off	(i) (ii)	700,302 ------------- 0	50,000 ------------- 0	40,757 ------------- 0	125,872 ------------- 0	41,394 ------------- 0	958,325 ------------- 0	0 ------------- 0
26David Perlin EVP, Chief Scientific Officer	(i) (ii)	542,085 ------------- 0	131,027 ------------- 0	131,273 ------------- 0	15,250 ------------- 0	18,721 ------------- 0	838,356 ------------- 0	0 ------------- 0
27Pranaychandra Vaidya MD Trustee/Med Dir	(i) (ii)	700,206 ------------- 0	32,924 ------------- 0	36,635 ------------- 0	15,250 ------------- 0	27,471 ------------- 0	812,486 ------------- 0	0 ------------- 0
28Aida Capo MD Trustee/Medical Director PMA	(i) (ii)	659,699 ------------- 25,120	15,000 ------------- 0	10,229 ------------- 0	15,250 ------------- 0	37,134 ------------- 0	737,312 ------------- 25,120	0 ------------- 0
29Amie Thornton Trustee/Sec/Treasurer/CHF	(i) (ii)	510,806 ------------- 0	110,985 ------------- 0	23,871 ------------- 0	67,522 ------------- 0	3,047 ------------- 0	716,231 ------------- 0	0 ------------- 0
30Regina Foley EVP, Chief Transformation Offi	(i) (ii)	464,691 ------------- 0	99,058 ------------- 0	23,495 ------------- 0	89,315 ------------- 0	29,774 ------------- 0	706,333 ------------- 0	0 ------------- 0
31Catherine A Ainora EVP, CIO (T 4/2/2022)	(i) (ii)	202,069 ------------- 0	404,279 ------------- 0	69,878 ------------- 0	12,720 ------------- 0	5,356 ------------- 0	694,302 ------------- 0	0 ------------- 0
32Donald J Parker Trustee/Pres Carrier Clinic	(i) (ii)	431,911 ------------- 0	153,305 ------------- 0	50,728 ------------- 0	15,212 ------------- 0	28,516 ------------- 0	679,672 ------------- 0	0 ------------- 0
33David Kountz VP, Academic Diversity & CAO	(i) (ii)	476,567 ------------- 0	88,360 ------------- 0	41,941 ------------- 0	24,400 ------------- 0	29,208 ------------- 0	660,476 ------------- 0	0 ------------- 0
34Harpreet Pall MD Trustee/Department Chair	(i) (ii)	495,262 ------------- 0	80,152 ------------- 0	35,781 ------------- 0	15,250 ------------- 0	15,169 ------------- 0	641,614 ------------- 0	0 ------------- 0
35Richard M Neibart MD Trustee/Srvc Medical Dir.	(i) (ii)	550,002 ------------- 0	0 ------------- 0	29,426 ------------- 0	15,250 ------------- 0	6,215 ------------- 0	600,893 ------------- 0	0 ------------- 0
36Suri Ponamgi MD Trustee/Chairman Sur(T 7/2022)	(i) (ii)	426,167 ------------- 0	15,000 ------------- 0	3,519 ------------- 0	15,250 ------------- 0	28,908 ------------- 0	488,844 ------------- 0	0 ------------- 0
37Surender M Grover MD Secretary/Vice Chair, MD Dept	(i) (ii)	259,401 ------------- 0	0 ------------- 0	3,582 ------------- 0	13,000 ------------- 0	1,673 ------------- 0	277,656 ------------- 0	0 ------------- 0
38Hans Schmidt Chief, Bariatric/Min Inv Surg	(i) (ii)	205,284 ------------- 0	5,883 ------------- 0	0 ------------- 0	3,792 ------------- 0	0 ------------- 0	214,959 ------------- 0	0 ------------- 0
39Mark D Schlesinger MD Trustee/Chair, Anesthesiology	(i) (ii)	155,472 ------------- 2,000	15,443 ------------- 0	3,150 ------------- 0	6,300 ------------- 0	12,997 ------------- 0	193,362 ------------- 2,000	0 ------------- 0
40Adrian M Pristas MD Trustee/Corp. Medical Director	(i) (ii)	132,464 ------------- 94,111	20,000 ------------- 0	1,534 ------------- 478	8,024 ------------- 0	22,369 ------------- 5,050	184,391 ------------- 99,639	0 ------------- 0
41Steven Lisser MD Trustee/Assoc Med Dir Ortho	(i) (ii)	155,766 ------------- 13,123	0 ------------- 0	0 ------------- 0	0 ------------- 0	0 ------------- 0	155,766 ------------- 13,123	0 ------------- 0

Schedule J (Form 990) 2022

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.

Return Reference	Explanation
SCHEDULE J, PART I; QUESTION 1A	CERTAIN BENEFITS, SUCH AS COMPANION TRAVEL, ARE PROVIDED ONLY AS EXCEPTIONS TO CORPORATE POLICY IN COMPELLING CIRCUMSTANCES INVOLVING STRONG BUSINESS PURPOSES. WHEN THESE BUSINESS-RELATED BENEFITS ARE APPROVED AND PROVIDED, HMH ALSO PROVIDES REIMBURSEMENT OF THE TAX, SO THAT THE BENEFIT IS PROVIDED WITHOUT COST TO THE INDIVIDUAL. THE TAX REIMBURSEMENTS WERE TREATED AS TAXABLE INCOME AND REPORTED AS SUCH ON THE FORM W-2 (OR 1099-MISC, IN THE CASE OF A BOARD MEMBER), AND INCLUDED IN THE AMOUNTS REPORTED IN SCHEDULE J FOR LISTED INDIVIDUALS. FIRST CLASS TRAVEL: HMH HAS A DETAILED AND THOROUGH CORPORATE POLICY ON REIMBURSEMENT OF BUSINESS EXPENSES, INCLUDING EXPENSES OF TRAVEL FOR BUSINESS PURPOSES. THE HMH EXPENSE REIMBURSEMENT POLICY GENERALLY PROHIBITS FIRST CLASS TRAVEL, BUT ALLOWS AN UPGRADE IN VERY LIMITED CIRCUMSTANCES. HMH ENCOURAGES SENIOR LEADERS TO UTILIZE THE TRAIN NETWORK FOR TRAVEL WHEN APPROPRIATE. HMH'S POLICY ALLOWS FOR BUSINESS CLASS TRAVEL (WHICH CAN BE THE EQUIVALENT OF FIRST CLASS TRAVEL, WHERE BUSINESS CLASS IS THE ONLY CLASS ABOVE ECONOMY/COACH), IF THE TRAVEL SEGMENT EXCEEDS TEN HOURS OF SCHEDULED FLYING TIME OR IF APPROVED BY THE CEO. THE BUSINESS CLASS AFFORDS THE TRAVELER THE ABILITY TO WORK ON CONFIDENTIAL HMH RELATED BUSINESS DURING TRAVEL TIME. UNLIKE BUSINESS CLASS, TRAVELING COACH DOES NOT PROVIDE THE EXECUTIVE WITH A REASONABLE MEANS TO WORK ON HMH BUSINESS DURING TRAVEL TIME. NO AMOUNTS HAVE BEEN INCLUDED AS REPORTABLE COMPENSATION AS THESE TRAVEL EXPENSES WERE INCURRED FOR BUSINESS PURPOSES. BUSINESS CLASS TRAVEL (WHERE THE EQUIVALENT OF FIRST CLASS TRAVEL) WAS PROVIDED TO FOUR SENIOR EXECUTIVES AND TWO BOARD MEMBERS. TRAVEL FOR COMPANIONS: HMH PROVIDES FOR BOARD MEMBERS AND CEO SPOUSAL TRAVEL FOR CRITICAL BUSINESS EVENTS THAT ARE ORDINARY AND NECESSARY. THE BOARD MEMBERS AND CEO SPEND AN EXTENSIVE AMOUNT OF TIME AWAY FROM THEIR FAMILIES. THE SPOUSES HAVE A SIGNIFICANT ROLE IN ASSURING THE ATTENDANCE AND FOCUS OF BOARD MEMBERS AND CEO AT THESE CRITICAL ORGANIZATION EVENTS. SUCH SPOUSAL TRAVEL WAS PROVIDED IN 2022 TO ONE BOARD MEMBER, AND THE ENTIRE SPOUSAL TRAVEL REIMBURSEMENT AMOUNT HAS BEEN TREATED AS TAXABLE INCOME TO THIS INDIVIDUAL.
SCHEDULE J, PART I; QUESTION 3	PLEASE REFER TO OUR RESPONSE TO CORE FORM, PART VI, SECTION B, QUESTIONS 15A & 15B INCLUDED IN SCHEDULE O.
SCHEDULE J; PART I; QUESTION 4B	THE AMOUNT REFLECTED IN COLUMN B(III) FOR THE FOLLOWING INDIVIDUALS INCLUDES PARTICIPATION IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ("SERP") AS THE AMOUNTS WERE NO LONGER SUBJECT TO A SUBSTANTIAL RISK OF COMPLETE FORFEITURE. THE AMOUNTS OUTLINED HEREIN WERE INCLUDED IN EACH INDIVIDUAL'S 2022 FORM W-2 AS TAXABLE WAGES: ROBERT C. GARRETT, FACHE, $904,854; ROBERT L. GLENNING, $384,734; TIMOTHY J. HOGAN, $362,506; ANN B. GAVZY, ESQ., $209,740; AUDREY C. MURPHY, ESQ., MSN, RN, $682,354; MARK STAUDER, $258,957; IHOR S. SAWCZUK, M.D., $227,681; KENNETH N. SABLE, M.D., $196,246; PATRICK YOUNG, $180,672; JAMES BLAZAR, $153,901; CATHERINE AINORA, $31,101; MARK D. SPARTA, M.D., $148,601; DANIEL VARGA, MD, $169,290; ANNE GOODWILL PRITCHETT, $99,662; JOYCE HENDRICKS, $98,594; TODD WAY, $136,617; ANDRE GOY, $233,754; LINDA MCHUGH, $162,100; DAVID PERLIN, $80,441; THERESA BRODRICK, $74,636, JEFFREY BOSCAMP, $86,763; AND JAMES CLARKE, $107,141. THE DEFERRED COMPENSATION AMOUNTS REFLECTED IN COLUMN (C) FOR THE FOLLOWING INDIVIDUALS INCLUDE BENEFITS IN AN INTERNAL REVENUE CODE SECTION 457(F) PLAN (NON-QUALIFIED DEFERRED COMPENSATION PLAN). THESE AMOUNTS ARE SUBJECT TO A SUBSTANTIAL RISK OF FORFEITURE. THESE INDIVIDUALS WILL NOT EARN THE RIGHT TO RECEIVE THE DEFERRED COMPENSATION AMOUNTS UNLESS AND UNTIL THEY PROVIDE SUBSTANTIAL FUTURE SERVICES TO THE ORGANIZATION. WHEN THE FUTURE SERVICES REQUIREMENT IS MET, THE AMOUNTS WILL BECOME VESTED, WILL BE TAXED, WILL BE INCLUDED ON THE W-2, AND WILL BE REPORTED AGAIN ON THIS SCHEDULE., KENNETH N. SABLE, M.D., PATRICK YOUNG, DONNA SNIDER, AMIE THORNTON, THERESA BRODRICK, REGINA FOLEY, KASH PATEL, AND MARK SPARTA.

Software ID:
Software Version: